Literature DB >> 23016860

Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms.

Chanse Fyffe1, Richard Buus, Marco Falasca.   

Abstract

The last quarter of a century has witnessed remarkable progress in the understanding of phosphoinositide 3-kinases (PI3K) signalling and their involvement in different diseases such as cancer, diabetes and inflammation. Nevertheless, many questions remain open and among these the role of genetic and epigenetic regulation of PI3K isoforms is one of the most prominent. Emerging evidence Indicates that levels of isoforms can be modulated upon stimulation or in both physiological and pathological conditions including increased gene copy number and transcription regulation. In addition, an intriguing role for epigenetic regulation of PI3K expression, caused by mechanisms other than changes in the underlying DNA sequence, are starting to get appreciated. In this review, we summarize the genetic and epigenetic regulation of PI3Ks in physiology and the role played by their alterations in different diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23016860

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

1.  Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase α.

Authors:  Ignacia Echeverria; Yunlong Liu; Sandra B Gabelli; L Mario Amzel
Journal:  FEBS J       Date:  2015-07-24       Impact factor: 5.542

Review 2.  Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer's Disease.

Authors:  Shaobin Yang; Yaqin Du; Xiaoqian Zhao; Chendong Wu; Peng Yu
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

Review 3.  Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts.

Authors:  Marco Falasca; Tania Maffucci
Journal:  Front Physiol       Date:  2014-10-15       Impact factor: 4.566

4.  Structural Perturbations due to Mutation (H1047R) in Phosphoinositide-3-kinase (PI3Kα) and Its Involvement in Oncogenesis: An in Silico Insight.

Authors:  Jatin Sharma; Vijay Bhardwaj; Rituraj Purohit
Journal:  ACS Omega       Date:  2019-09-20

Review 5.  3-Phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer.

Authors:  Chanse Fyffe; Marco Falasca
Journal:  Cancer Manag Res       Date:  2013-08-23       Impact factor: 3.989

6.  Structural basis of nSH2 regulation and lipid binding in PI3Kα.

Authors:  Michelle S Miller; Oleg Schmidt-Kittler; David M Bolduc; Evan T Brower; Daniele Chaves-Moreira; Marc Allaire; Kenneth W Kinzler; Ian G Jennings; Philip E Thompson; Philip A Cole; L Mario Amzel; Bert Vogelstein; Sandra B Gabelli
Journal:  Oncotarget       Date:  2014-07-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.